Mar 24, 2020 8:30am EDT Algernon Provides an Overview of its NP-120 (Ifenprodil) Program for COVID-19
Mar 23, 2020 8:30am EDT Algernon Appoints U.S. Company for cGMP Manufacturing of NP-120 (Ifenprodil) for COVID-19 Clinical Trials
Mar 13, 2020 2:56pm EDT Algernon Contacts Gates Foundation Regarding Funding for New Coronavirus Treatments
Mar 13, 2020 8:30am EDT Algernon Announces Filing of U.S. FDA Pre-IND Meeting Request for Ifenprodil Coronavirus Trial, Expanded Access, and Emergency Use
Mar 10, 2020 8:46am EDT Algernon Announces Coronavirus Update Featured on BioPub Hosted by Dr. KSS MD PhD
Mar 09, 2020 8:45am EDT Algernon Scales up Manufacturing of NP-120 (Ifenprodil) to Prepare for Coronavirus and Acute Lung Injury US Clinical Trials
Mar 06, 2020 2:34pm EST Algernon Announces Availability of its NP-120 Ifenprodil Drug for Compassionate Use for Coronavirus
